Overview
Medivis, founded by Osamah Choudhry and Christopher Morley, former senior residents at NYU Medical Center, stands at the forefront of medical technology innovation. Their groundbreaking solution, SurgicalAR, harnesses the power of Augmented Reality, AI and computer vision to provide surgeons with real-time patient information and essential 3D displays, empowering them to make more informed decisions during surgical procedures.
Collaborating with esteemed institutions like the University of Pennsylvania and New York University, Medivis has seamlessly integrated prototypes into surgical settings. This collaborative effort underscores the company's commitment to advancing medical technology through strategic partnerships.
Christopher Morley, emphasizing their focus, highlights Medivis' dedication to innovation at the convergence of medical imaging and surgical utility. The company seeks to disrupt the industry with its 3D pipeline, automating the rendering process and offering swift interfaces for surgical planning.
In terms of their current product offering, Medivis provides a comprehensive package including a touchscreen monitor, display, and a headset (Miscrosoft’s Hologram 2). This seamlessly connects to hospital networks, extracting medical imaging for display within a remarkable 30 seconds. This technology proves especially valuable in the pre-surgical planning stage, streamlining a traditionally complex process that involves multiple components.
With its roots in the collaborative efforts of medical experts and a commitment to technological advancement, Medivis is revolutionizing the field and providing indispensable tools for various medical professionals, including plastic surgeons, neurosurgeons, ENTs, and orthopedic surgeons.
Whats the need of SurgicalAR in healthcare industry
The need for SurgicalAR in the healthcare industry is paramount, as Medivis endeavors to not only support medical professionals but also ensure swift and accurate treatment for patients. Christopher Morley illustrates this necessity through a compelling example in a case study. He highlights the challenges faced in CT-guided catheter placements, where despite using 10 CT scans over 2.5 hours, an average error of 2.2 cm persisted. In contrast, SurgicalAR has the capability to significantly reduce this error to less than 2 mm, requiring only one CT scan. This is particularly crucial in cases where precision is essential, such as guiding a catheter into the brain's ventricle to alleviate critical intracranial pressure.
Research indicates an inaccuracy rate of 20-30% in such procedures, a gap that SurgicalAR addresses by directly registering the patient's CT onto them. The system then guides the catheter in real-time, ensuring precise navigation and hitting the intended target with accuracy. The integration of positional instrument tracking further enhances the surgeon's capabilities, providing information on the specific point and angle at which instruments should be placed.
SurgicalAR's impact is substantiated by its extensive usage in over 500 surgeries, spanning various medical specialties like oncology, trauma, vascular anomalies, and congenital malformations. This revolutionary technology transforms conventional methods, shifting from the reliance on computers and 2D displays to the simplicity of wearing an AR headset. Medivis eliminates the need for infrared tracking systems, streamlining the surgical process and enabling surgeons to access essential data seamlessly.
Medivis' groundbreaking AR platform goes beyond conventional approaches, allowing surgeons to holographically render patients' MRI and CT imaging. This reveals internal anatomy in unprecedented detail. The system ensures a secure connection to the PACS server, operating efficiently in 10 seconds or less for any patient, thereby enhancing the overall efficiency and precision of surgical interventions.
If you wish to learn more about Medivis SurgicalAR Technology, you can view their webpage here :
